Zoomlion Advances Intelligent Agricultural Machinery and Upgrades Service Support to Safeguard Summer Grain Harvest
CHANGSHA, China, June 9, 2025 /PRNewswire/ — Zoomlion Heavy Industry Science & Technology Co., Ltd. (“Zoomlion”; 1157.HK) is spearheading all-out... Read more.
BingX and Chelsea FC Unveil 25/26 Training Kit with “Trained on Greatness” Campaign
PANAMA CITY, June 9, 2025 /PRNewswire/ — BingX, a global leading cryptocurrency exchange and Web3 AI company, is proud to share the reveal of the 2025/26... Read more.
Trust3 AI Announces Trust AI for Databricks
SAN FRANCISCO, June 9, 2025 /PRNewswire/ — Trust3 AI has announced the launch of Trust AI for Databricks, an innovative trust layer solution designed to empower... Read more.
Level2 Partners with Lightspeed to Deliver Intuitive, No-Code Systematic Trading Solutions for Active Traders
LONDON, June 9, 2025 /PRNewswire/ — Level2 and Lightspeed Financial Services Group LLC are joining forces to empower a new generation of active traders through... Read more.
Clarivate Partners with American Library Association to Advocate for U.S. Libraries
LONDON, June 9, 2025 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new milestone in... Read more.
Power Metallic Acquires 167KM² from Li-FT Power, Expanding Nisk – Lion Polymetallic Project Area by over 300%
TORONTO, June 9, 2025 /PRNewswire/ – Power Metallic Mines Inc. (the “Company” or “Power Metallic”) (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt:... Read more.
Middle East Cybersecurity Market worth $26.04 billion by 2030- Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., June 9, 2025 /PRNewswire/ — The Middle East Cybersecurity Market will grow to USD 26.04 billion by 2030 from USD 16.75 billion in 2025,... Read more.
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
LUND, Sweden, June 9, 2025 /PRNewswire/ — Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor... Read more.
Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association
EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN) and other... Read more.
28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains
Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLEANS, June... Read more.